Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Pharmacology|January 1, 1980
A controlled trial of senna preparations and other laxatives used for bowel cleansing prior to radiological examinationJ R Brouwers, W P van Ouwerkerk, S M de Boer, et al.Journal of Virology|October 5, 2012
Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion proteinS M de Boer, J Kortekaas, L Spel, et al.Vaccine|May 4, 2010
Rift Valley fever virus immunity provided by a paramyxovirus vaccine vectorJ Kortekaas, S M de Boer, J Kant, et al.Journal of Virology|September 28, 2012
Heparan sulfate facilitates Rift Valley fever virus entry into the cellS M de Boer, J Kortekaas, C A M de Haan, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 12, 2024
Dosimetric impact of bone marrow sparing for robustly optimized IMPT for locally advanced cervical cancerS C Kuipers, J Godart, A Corbeau, et al.Microbiology Spectrum|August 27, 2025
Evaluation of commercial rapid tests for fast and on-site detection of high-pathogenicity avian influenza H5 virus in poultryF J van der Wal, S B E Pritz-Verschuren, E A Germeraad, et al.Vaccine|January 9, 2010
Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challengeS M de Boer, J Kortekaas, A F Antonis, et al.Vaccine|January 19, 2010
Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virusJ Kortekaas, A Dekker, S M de Boer, et al.Vaccine|March 28, 2012
Efficacy of three candidate Rift Valley fever vaccines in sheepJ Kortekaas, A F G Antonis, J Kant, et al.Science (New York, N.Y.)|November 4, 2017
A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertionP Guardado-Calvo, K Atkovska, S A Jeffers, et al.Pageof 2